Genies is a new app that launched late last year which allows users to create personalizable look-alike and expressive emojis that react to what’s going on in real-time -- everything from breaking news to cultural holidays. CEO Akash Nigam sits down with Cheddar to talk about what went into creating the app, including the company's proprietary AI technology designed to make the app the first of its kind. Nigam acknowledged that the emoji space is becoming more saturated, but insists Genie is creating something that will stand out from the crowd. The young CEO, who was nominated for Forbes 30 under 30 in 2016, recently raised $15 million in investor funding to further develop the technology. He also discusses the value of having celebrities like Shawn Mendes and Chainsmokers attached to the brand as investors and celebrity ambassadors. Nigam says the company plans to make Bitmoji obsolete with its new upgraded technology.

Share:
More In Business
Poll: More Americans think companies benefit from legal immigration
A new poll finds U.S. adults are more likely than they were a year ago to think immigrants in the country legally benefit the economy. That comes as President Donald Trump's administration imposes new restrictions targeting legal pathways into the country. The Associated Press-NORC Center for Public Affairs Research survey finds Americans are more likely than they were in March 2024 to say it’s a “major benefit” that people who come to the U.S. legally contribute to the economy and help American companies get the expertise of skilled workers. At the same time, perceptions of illegal immigration haven’t shifted meaningfully. Americans still see fewer benefits from people who come to the U.S. illegally.
Tylenol maker rebounds a day after unfounded claims about its safety
Shares of Tylenol maker Kenvue are bouncing back sharply before the opening bell a day after President Donald Trump promoted unproven and in some cases discredited ties between Tylenol, vaccines and autism. Trump told pregnant women not to use the painkiller around a dozen times during the White House news conference Monday. The drugmaker tumbled 7.5%. Shares have regained most of those losses early Tuesday in premarket trading.
Load More